1 Product identity
Ingredient risk
2 ingredients to use with caution
B12
BrandBioclinic Naturals→Vitamin Lozenge 5 ingredients 2 caution DSLD #20788Net contents: 60 Lozenge(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-04-25
2 Ingredients (5)
IngredientGroupSafety
LactoseLactose—
CelluloseCellulose—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Vitamin B12 — Nitrous oxide anesthesia in subclinically B12-deficient patients can precipitate acute combined degeneration — always check B12 before elective p…
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Vitamin B12 — Use with Caution
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID20788
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-04-25
6 More from Bioclinic Naturals
View Bioclinic Naturals Safety Scorecard → 37 products
AlkaCare pHBioFoundation-GBioLivXBioLivXCalm-Pro Tropical BreezeClear-HM7 Cite this page
Vancouver
Pkhakadze G. B12 — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jul 27]. Available from: https://supplement.ge/products/b12-20788/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG